Replies to post #8923 on Humanigen Inc (HGENQ)

[roygbiv]

"exclusion criteria is any and all confirmed ARDS patients."

Think further upstream before progression of ARDS.

This video should help in your understanding of why the above exclusion exists. Treatment is most effective before a CRS event.

https://www.humanigen.com/covid-19

Humanigen is also planning a Phase III clinical trial to evaluate lenzilumab for the prevention and treatment of cytokine storm arising from COVID-19, which can lead to acute respiratory distress syndrome (ARDS) and/or death in some patients.